Hydrochlorothiazide description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

Hydrochlorothiazide

REMEDYREPACK INC.


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

HYDROCHLOROTHIAZIDE DESCRIPTION


Hydrochlorothiazide





CLINICAL PHARMACOLOGY






Pharmacokinetics and Metabolism


INDICATIONS & USAGE





Use in Pregnancy

PRECAUTIONS, Pregnancy

HYDROCHLOROTHIAZIDE CONTRAINDICATIONS




WARNINGS






PRECAUTIONS, Drug Interactions

Acute Myopia and Secondary Angle-Closure Glaucoma


PRECAUTIONS

General











LABORATORY TESTS



DRUG INTERACTIONS












DRUG & OR LABORATORY TEST INTERACTIONS

PRECAUTIONS, General

CARCINOGENESIS & MUTAGENESIS & IMPAIRMENT OF FERTILITY





PREGNANCY

Teratogenic Effects

Pregnancy Category B



Nonteratogenic Effects


NURSING MOTHERS



PEDIATRIC USE

DOSAGE AND ADMINISTRATION, Infants and Children

HYDROCHLOROTHIAZIDE ADVERSE REACTIONS







PRECAUTIONS


WARNINGS





OVERDOSAGE




DOSAGE & ADMINISTRATION



Adults

For Edema


For Control of Hypertension
PRECAUTIONS


Infants and Children

For Diuresis and For Control of Hypertension
PRECAUTIONS, Pediatric Use

HOW SUPPLIED



  • ●Bottles of 10: NDC 0603-3856-10
  • ●Bottles of 30: NDC 0603-3856-16
  • ●Bottles of 50: NDC 0603-3856-19
  • ●Bottles of 100: NDC 0603-3856-21
  • ●Bottles of 500: NDC 0603-3856-28
  • ●Bottles of 1000: NDC 0603-3856-32
  • ●Bottles of 5000: NDC 0603-3856-34
  • ●Hydrochlorothiazide Tablets, USP 50 mg, are peach-colored, round, scored tablets debossed "3572" and "V" on one side.


  • ●Bottles of 30: NDC 0603-3857-16
  • ●Bottles of 50: NDC 0603-3857-19
  • ●Bottles of 100: NDC 0603-3857-21
  • ●Bottles of 500: NDC 0603-3857-28
  • ●Bottles of 1000: NDC 0603-3857-32

STORAGE AND HANDLING




PACKAGE LABEL.PRINCIPAL DISPLAY PANEL SECTION














Hydrochlorothiazide



Hydrochlorothiazide


Hydrochlorothiazide

Hydrochlorothiazide TABLET

Product Information

Product Type Human prescription drug label Item Code (Source) NDC:49349-923(NDC:0603-3856)
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
HYDROCHLOROTHIAZIDE HYDROCHLOROTHIAZIDE 25 mg

Inactive Ingredients

Ingredient Name Strength
FD&C YELLOW NO. 6
lactose monohydrate
MAGNESIUM STEARATE
cellulose, microcrystalline
STARCH, CORN

Product Characteristics

Color Size Imprint Code Shape
orange 6 mm 3571;V ROUND

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:49349-923-38 3 in 1 BLISTER PACK

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA040412 2012-03-15


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.